Ultima Genomics, founded in 2016, has raised $600 million across Seed, Series A, and Series B funding rounds, reaching a $1 billion valuation. Its largest raise was a $430 million Series B in 2021 led by SoftBank Vision Fund and Illumina Ventures. Ultima Genomics develops high throughput DNA sequencing technologies aimed at reducing cost and increasing speed and accuracy. With strong investor backing, the company is positioned to scale genomic research, precision medicine applications, and adoption of affordable next generation sequencing solutions globally.